Pharmaceutical Acquisitions

Eli Lilly Announces $2.4B Acquisition of Immunology Company Dice Therapeutics

June 23, 2023 - Monday, Eli Lilly announced that it would acquire Dice Therapeutics for $2.4 billion in cash, representing a 40% premium on the recent trading value of the smaller firm. Lilly’s purchase agreement brings aboard several early-stage immunology products and the DELSCAPE small molecule discovery platform. Currently, DICE has one oral psoriasis...

Read More


More Articles

Envision Pharma Group Acquires OKRA.ai

by Hayden Schmidt

This week, Envision Pharma Group announced that it had acquired OKRA.ai, a leader in artificial intelligence solutions for pharmaceutical operations. The transaction will add OKRA’s founder to...

AstraZeneca Purchases CinCor Pharma Inc. in $1.8 Billion Acquisition

by Hayden Schmidt

This week, AstraZeneca announced its acquisition of Massachusetts-based CinCor Pharma as part of a transaction worth $1.8 billion. CinCor will support AstraZeneca’s mission to accelerate...

Moderna to Buy Japanese Firm OriCiro in Its First-Ever Acquisition

by Hayden Schmidt

Moderna Inc and Japan-based OriCiro Genomics K.K. reached an agreement on Wednesday wherein Moderna will acquire OriCiro and its suite of biopharmaceutical applications for $85...

Amgen’s $27.8 Billion Rare Disease Drug Acquisition

by Hayden Schmidt

On Monday, Amgen Inc announced its acquisition of the rare disease pharmaceutical company Horizon Therapeutics PLC, building on its portfolio of key drugs for treating uncommon conditions. Amgen...

J&J Preps for Consumer Health Spin-Off, Purchases Abiomed for $16.6B

by Hayden Schmidt

Pharmaceutical company Johnson & Johnson struck a deal Tuesday to acquire Abiomed, the heart pump manufacturer. J&J will pay $16.6 billion in cash for the acquisition, valuing the stock at $380...

Walgreens’ $1.67-Billion Specialty Pharmacy and Home Health Play

by Hayden Schmidt

On August 24, 2022, Walgreens lost a court case where it, and two other retail pharmacies, were ordered to pay $650.5 million to two Ohio Counties for their role in the opioid epidemic. One week after...

Pfizer Buys Global Blood Therapeutics for $5.4B, Continues Acquisition Splurge

by Hayden Schmidt

Pfizer is back at it with another acquisition, this time scooping up the rare disease pharmaceutical company Global Blood Therapeutics for $5.4 billion in cash. Pfizer’s acquisition will cede...

Merck & Co.‘s $40B Acquisition of Pharmaceutical Company Seagen

by Hayden Schmidt

The prospective Merck & Co. acquisition of Seattle-based biotech firm Seagen would be the largest pharmaceutical acquisition since 2020 if it is completed. Initial indications that Merck was...

Pfizer Acquires ReViral for $525M, Renews Pharma Acquisition Spree

by Hayden Schmidt

Pfizer has announced or completed the acquisition of four pharmaceutical companies in the past year. The most recent of which incorporated ReViral Ltd, adding another antiviral drugmaker to...

Eli Lilly Invest $2.1B in Indiana Pharmaceutical Manufacturing

by Hayden Schmidt

Pharmaceutical giant, Eli Lilly, will extend its operations in Indiana, adding two additional manufacturing facilities with a $2.1 billion investment. Lilly will use the new facilities to produce...

Pfizer Acquires Biohaven Pharmaceutical for $11.6 Billion in Cash

by Hayden Schmidt

Pfizer Inc. and Biohaven Pharmaceutical announced that Pfizer will acquire Biohaven for $11.6 billion in cash after years of collaborative drug development, improving access to medicine used to treat...

Amgen Acquires Five Prime in $1.9B Pharma Acquisition Deal

by Samantha McGrail

Amgen has acquired Five Prime Therapeutics in a $1.9 billion pharma acquisition deal to advance its immuno-oncology and targeted cancer therapies portfolio.  The acquisition adds Five...

Pharmaceutical Mergers, Acquisitions Down in First Half of 2020

by Samantha McGrail

A recent PwC insights analysis found that the pharmaceutical merger and acquisition activity saw a notable decline in the first half of 2020, but the potential for consolidation in specific sub-sectors...

FTC, NY Sue to Ban Martin Shkreli From Pharmaceutical Industry

by Ana Mulero

The Federal Trade Commission and the New York Attorney General Letitia James filed a complaint in federal court against Vyera Pharmaceuticals, Martin Shkreli and Kevin Mulleady, seeking to ban the...

Biotech to be ‘Extremely Active’ in 2020 Mergers and Acquisitions

by Ana Mulero

A PriceWaterhouseCoopers report predicts biotechnology firms will be “extremely active” in merger and acquisition activity and drive pharmaceutical firms’ activity in 2020. Last year...

2020 Poised to be Another Life Sciences M&A ‘Mega’ Year

by Ana Mulero

2020 will be another blockbuster year for life sciences mergers and acquisitions, according to a recent report from Ernst & Young Health Sciences and Wellness. And companies' interest in...

FTC Thwarts $1.2B Illumina-Pacific Biosciences Takeover

by Ana Mulero

California-based manufacturers of next-generation DNA sequencing (NGS) technology platforms Illumina and Pacific Biosciences of California (PacBio) recently decided to terminate their $1.2-billion...

FTC Moves to Block Illumina Acquisition of PacBio, Citing Monopoly

by Kyle Murphy, PhD

On Tuesday, the Federal Trade Commission (FTC) took legal action to block Illumina Inc.’s acquisition of Pacific Biosciences of California (PacBio) as part of an administrative complaint alleging...

Top 5 Life Sciences Companies by Pharmaceutical Sales

by Kyle Murphy, PhD

The pharmaceutical industry is inching closer to the $1.3 trillion mark, with future growth anticipated for life sciences companies worldwide. According to the IQVIA Institute, the global...

Recent Articles